ClinicalTrials.Veeva

Menu

Oral Curcumin Supplementation in Middle-Aged and Older Adults Improves Vascular Function

U

University of Colorado Boulder (CU)

Status

Unknown

Conditions

Vascular Aging

Treatments

Drug: Placebo pill
Drug: Low-dose curcumin pill
Drug: High-dose curcumin pill

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The proposed study will assess the ability of curcumin, the active ingredient in the Indian spice tumeric, to improve the function of arteries with age. Overall, the proposed research project has the long-term potential to influence clinical practice guidelines by establishing a novel, easy to deliver, cost-effective therapy for treating age-associated arterial dysfunction and reducing the risk of cardiovascular disease with age.

Enrollment

118 patients

Sex

All

Ages

45 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • women must be postmenopausal
  • body mass index (BMI) <40 kg/m2
  • weight stable in the prior 3 months
  • absence of clinical disease as determined by medical history, physical examination, blood and urine chemistries, ankle-brachial index, and a graded exercise stress test with monitoring of blood pressure and 12-lead ECG

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

118 participants in 3 patient groups, including a placebo group

High-dose curcumin pill
Experimental group
Treatment:
Drug: High-dose curcumin pill
Low-dose curcumin pill
Experimental group
Treatment:
Drug: Low-dose curcumin pill
Placebo pill
Placebo Comparator group
Treatment:
Drug: Placebo pill

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems